Novacyt SA
LSE:NCYT
Novacyt SA
LSE:NCYT
Price:
33.65
GBX
-2.18%
Market Cap:
£23.8m
Add Note
Add Target
Capture your thoughts and set a target
Decide at what price you'd be comfortable buying and we'll help you stay ready.
Based on
Margin of Safety
0%
10%
20%
30%
40%
50%
Your Price Target
Linked to
current price
· In Buy Zone
Loading
Note attached
Choose the stock you wish to monitor with a price target
Recently Viewed
|
N
|
Novacyt SA
LSE:NCYT
|
FR |
|
Oportun Financial Corp
NASDAQ:OPRT
|
US |
|
Sharda Motor Industries Ltd
NSE:SHARDAMOTR
|
IN |
|
E
|
Eli Lilly and Co
F:LLY
|
US |
|
W
|
Wuxi Online Offline Communication Information Technology Co Ltd
SZSE:300959
|
CN |
|
Orapi SA
PAR:ORAP
|
FR |
|
ShenZhen Yitoa Intelligent Control Co Ltd
SZSE:300131
|
CN |
|
Cita Mineral Investindo Tbk PT
IDX:CITA
|
ID |
Multiples-Based Value
The Multiples-Based Value of one
NCYT
stock under the Base Case scenario is
hidden
GBX.
Compared to the current market price of 33.65 GBX,
Novacyt SA
is
hidden
.
Multiples-Based Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.
Relative Valuation FAQ:
NCYT Multiples-Based Value
LOCKED
Multiples Across Competitors
NCYT Competitors Multiples
Novacyt SA Competitors
Novacyt SA Competitors
All Countries
| Market Cap | P/S | P/E | EV/EBITDA | EV/EBIT | ||||
|---|---|---|---|---|---|---|---|---|
| FR |
|
Novacyt SA
LSE:NCYT
|
27.2m GBP | 1.2 | -0.8 | -0.8 | -0.8 | |
| FR |
|
Pharnext SCA
OTC:PNEXF
|
6T USD | 33 690 872.8 | -160 127.7 | -194 446.1 | -192 227.3 | |
| US |
|
Abbvie Inc
NYSE:ABBV
|
384.5B USD | 6.3 | 91.9 | 15.2 | 21.1 | |
| US |
|
Exact Sciences Corp
NASDAQ:EXAS
|
361.6B USD | 111.3 | -1 738.3 | 16 147.7 | -1 823.3 | |
| US |
|
Amgen Inc
NASDAQ:AMGN
|
189.6B USD | 5.2 | 24.6 | 14.2 | 14.2 | |
| US |
|
Gilead Sciences Inc
NASDAQ:GILD
|
173B USD | 5.9 | 20.3 | 12.7 | 15.7 | |
| US |
|
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
|
113.4B USD | 9.5 | 28.7 | 21.6 | 22.5 | |
| US |
E
|
Epizyme Inc
F:EPE
|
94.1B EUR | 2 091 | -533.6 | -581 | -565.5 | |
| US |
|
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
|
81.7B USD | 5.7 | 18.1 | 13.6 | 15.5 | |
| AU |
|
CSL Ltd
ASX:CSL
|
67.9B AUD | 3.1 | 34.5 | 11.4 | 14.3 | |
| US |
S
|
Seagen Inc
F:SGT
|
39.3B EUR | 20.1 | -61.8 | -66.6 | -60.1 |
P/S Multiple
P/E Multiple
EV/EBITDA Multiple
EV/EBIT Multiple
